Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 4 | 2022 | 334 | 1.090 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 163 | 1.050 |
Why?
|
| E2F Transcription Factors | 4 | 2019 | 48 | 0.990 |
Why?
|
| E2F1 Transcription Factor | 2 | 2017 | 44 | 0.590 |
Why?
|
| E2F3 Transcription Factor | 2 | 2017 | 46 | 0.580 |
Why?
|
| E2F7 Transcription Factor | 2 | 2016 | 15 | 0.580 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 18 | 0.570 |
Why?
|
| Gene Dosage | 1 | 2017 | 47 | 0.570 |
Why?
|
| Repressor Proteins | 2 | 2016 | 183 | 0.530 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 307 | 0.480 |
Why?
|
| Liver | 2 | 2022 | 1118 | 0.410 |
Why?
|
| Neoplasms | 1 | 2019 | 1667 | 0.300 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1174 | 0.250 |
Why?
|
| Mice | 7 | 2022 | 8474 | 0.200 |
Why?
|
| Gene Deletion | 3 | 2018 | 235 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
| Animals | 8 | 2022 | 20881 | 0.180 |
Why?
|
| Hepatocytes | 3 | 2018 | 205 | 0.180 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 14 | 0.170 |
Why?
|
| Multigene Family | 1 | 2019 | 93 | 0.160 |
Why?
|
| Protein Stability | 1 | 2019 | 90 | 0.160 |
Why?
|
| Endoreduplication | 1 | 2018 | 3 | 0.160 |
Why?
|
| Origin Recognition Complex | 1 | 2018 | 5 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.150 |
Why?
|
| Genome | 1 | 2018 | 54 | 0.150 |
Why?
|
| DNA Damage | 1 | 2019 | 190 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 284 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
| Protein Domains | 1 | 2016 | 74 | 0.140 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 75 | 0.130 |
Why?
|
| Alleles | 1 | 2016 | 386 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2016 | 312 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 320 | 0.120 |
Why?
|
| Biopsy | 1 | 2016 | 540 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 786 | 0.120 |
Why?
|
| DNA | 1 | 2016 | 597 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 901 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 1027 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1692 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 226 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 164 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 219 | 0.100 |
Why?
|
| Humans | 6 | 2022 | 68618 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
| Embryonic Development | 2 | 2018 | 100 | 0.060 |
Why?
|
| Diet, Western | 1 | 2022 | 17 | 0.050 |
Why?
|
| Glycosylation | 1 | 2022 | 185 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 284 | 0.050 |
Why?
|
| Pregnancy | 2 | 2018 | 2334 | 0.040 |
Why?
|
| Female | 3 | 2018 | 38074 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 301 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2018 | 38 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 83 | 0.040 |
Why?
|
| Mitosis | 1 | 2018 | 76 | 0.040 |
Why?
|
| Placenta | 1 | 2018 | 101 | 0.040 |
Why?
|
| Cell Division | 1 | 2018 | 541 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2018 | 791 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1030 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 124 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2550 | 0.030 |
Why?
|
| Male | 1 | 2016 | 37321 | 0.030 |
Why?
|
| Giant Cells | 1 | 2012 | 14 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2012 | 29 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 2012 | 29 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 52 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 63 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 261 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 489 | 0.020 |
Why?
|
| Zebrafish | 1 | 2012 | 187 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 615 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 1851 | 0.020 |
Why?
|